Clinical Case Studies in Long-Term Care Psychiatry Navigating Common Mental Health Challenges in Geriatric Care
Book contents
- Clinical Case Studies in Long-Term Care Psychiatry
- Clinical Case Studies in Long-Term Care Psychiatry
- Copyright page
- Contents
- Preface
- Section 1 Neurocognitive Disorders
- Case 2 “I Think I Hit My Head”
- Case 3 “It’s like She’s a Different Person”
- Case 4 “I Am Tired All the Time”
- Case 5 “I Am Okay”
- Case 6 “Leave Me Alone”
- Case 7 “I Am Fine”
- Case 8 “Those Children Are Cute”
- Case 9 “Those Terrible Men Have Left”
- Case 10 “I Saw the Heavenly Gates”
- Case 11 “Leave Me Alone”
- Section 2 Mood Disorders
- Case 13 “My Mom Looks Like a Zombie!”
- Case 14 “My Soul Is in England”
- Case 15 “I Feel Terrible”
- Case 16 “I Don’t Care”
- Case 17 “I Feel Very Lonely”
- Case 18 “I Don’t Feel Right”
- Case 19 “I Am Feeling Great”
- Case 20 “I Am Staying Here Illegally”
- Section 3 Psychotic Disorders
- Case 22 “He Just Won’t Get Up”
- Case 23 “My Body Is Being Taken over by a Fungus!”
- Case 24 “This Is Humiliating”
- Case 25 “I Want to Go Home”
- Case 26 “I Am a Worrier”
- Case 27 “Get out of My House”
- Section 4 Anxiety and Related Disorders
- Case 29 “My Vision Has Been Worsening in the Last Two Weeks”
- Case 30 “I Am Not Addicted to Valium”
- Case 31 “Of Course, I Worry about Him”
- Case 32 “Bombs Are Falling! Run, Run!”
- Section 5 Substance Abuse Disorders
- Section 6 Personality Disorders
- Case 35 “I Cannot Wait to Get out of This Miserable Place”
- Section 7 Miscellaneous Neuropsychiatric Disorders Affecting Patients in Long-Term Care
- Case 37 “Everyone Is Just So Good to Me!”
- Case 38 “Why Do They Say I Have Dementia?”
- Case 39 “I Hate That Guy … I Can’t Get Any Sleep!”
- Case 40 “Just One Kiss”
- Case 41 “I Don’t Feel Well”
- Case 42 “I Like Food”
- Case 43 “I Like the Way She Laughs”
- Case 44 “This Is So Hard”
- Index
- References
Case 24 - “This Is Humiliating”
Clozapine
Published online by Cambridge University Press: 31 October 2024
Book contents
- Clinical Case Studies in Long-Term Care Psychiatry
- Clinical Case Studies in Long-Term Care Psychiatry
- Copyright page
- Contents
- Preface
- Section 1 Neurocognitive Disorders
- Case 2 “I Think I Hit My Head”
- Case 3 “It’s like She’s a Different Person”
- Case 4 “I Am Tired All the Time”
- Case 5 “I Am Okay”
- Case 6 “Leave Me Alone”
- Case 7 “I Am Fine”
- Case 8 “Those Children Are Cute”
- Case 9 “Those Terrible Men Have Left”
- Case 10 “I Saw the Heavenly Gates”
- Case 11 “Leave Me Alone”
- Section 2 Mood Disorders
- Case 13 “My Mom Looks Like a Zombie!”
- Case 14 “My Soul Is in England”
- Case 15 “I Feel Terrible”
- Case 16 “I Don’t Care”
- Case 17 “I Feel Very Lonely”
- Case 18 “I Don’t Feel Right”
- Case 19 “I Am Feeling Great”
- Case 20 “I Am Staying Here Illegally”
- Section 3 Psychotic Disorders
- Case 22 “He Just Won’t Get Up”
- Case 23 “My Body Is Being Taken over by a Fungus!”
- Case 24 “This Is Humiliating”
- Case 25 “I Want to Go Home”
- Case 26 “I Am a Worrier”
- Case 27 “Get out of My House”
- Section 4 Anxiety and Related Disorders
- Case 29 “My Vision Has Been Worsening in the Last Two Weeks”
- Case 30 “I Am Not Addicted to Valium”
- Case 31 “Of Course, I Worry about Him”
- Case 32 “Bombs Are Falling! Run, Run!”
- Section 5 Substance Abuse Disorders
- Section 6 Personality Disorders
- Case 35 “I Cannot Wait to Get out of This Miserable Place”
- Section 7 Miscellaneous Neuropsychiatric Disorders Affecting Patients in Long-Term Care
- Case 37 “Everyone Is Just So Good to Me!”
- Case 38 “Why Do They Say I Have Dementia?”
- Case 39 “I Hate That Guy … I Can’t Get Any Sleep!”
- Case 40 “Just One Kiss”
- Case 41 “I Don’t Feel Well”
- Case 42 “I Like Food”
- Case 43 “I Like the Way She Laughs”
- Case 44 “This Is So Hard”
- Index
- References
Summary
Clozapine is now an important medication in the treatment of schizophrenia. It is used primarily in cases of treatment-resistant schizophrenia but is also useful in patients with schizophrenia that have had adverse effects to multiple other antipsychotics. The use of clozapine in schizophrenia has several benefits in addition to improving the control of the symptoms of schizophrenia for those with treatment-resistant schizophrenia. The risks of using clozapine are well known and the most feared side effect of clozapine is agranulocytosis. Agranulocytosis risk is highest in the first three months of use of the drug but is possible even after years of use. There are some off-label uses of clozapine that healthcare providers in long-term care should be aware of. Some studies have suggested that clozapine may be effective in treating treatment-resistant depression. Clozapine has been used off-label in the treatment of bipolar disorder, particularly in people who have not responded to other more commonly prescribed medications.
- Type
- Chapter
- Information
- Clinical Case Studies in Long-Term Care PsychiatryNavigating Common Mental Health Challenges in Geriatric Care, pp. 117 - 120Publisher: Cambridge University PressPrint publication year: 2024
References
Syme, M. (2014). The evolving concept of older adult sexual behavior and its benefits. Generations, 38 (1), 35–41.Google Scholar
Howard, L., Brassolotto, J., & Manduca-Barone, A. (2020). Navigating tensions about resident sexual expression in Alberta’s continuing care homes: A qualitative study of leaders’ experiences. Sexuality Research and Social Policy, 17, 632–642.CrossRefGoogle Scholar
National Collaborating Centre for Mental Health (UK). (2014). Psychosis and schizophrenia in adults: Treatment and management.Google Scholar
Lally, J., & MacCabe, J. H. (2015). Antipsychotic medication in schizophrenia: A review. British Medical Bulletin, 114 (1), 169–179.CrossRefGoogle ScholarPubMed
Vermeulen, J. M., van Rooijen, G., van de Kerkhof, M. P., Sutterland, A. L., Correll, C. U., & de Haan, L. (2019). Clozapine and long-term mortality risk in patients with schizophrenia: A systematic review and meta-analysis of studies lasting 1.1–12.5 years. Schizophrenia Bulletin, 45 (2), 315–329.CrossRefGoogle ScholarPubMed
Abou-Saleh, M. T. (2004). Psychopharmacology of substance misuse and comorbid psychiatric disorders. Acta Neuropsychiatrica, 16 (1), 19–25.CrossRefGoogle ScholarPubMed
Schulte, P. F. (2006). Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Annals of Pharmacotherapy, 40 (4), 683–688.CrossRefGoogle ScholarPubMed
Li, K. J., Gurrera, R. J., & Delisi, L. E. (2018). Potentially fatal outcomes associated with clozapine. Schizophrenia Research, 199, 386–389.CrossRefGoogle ScholarPubMed
Haslemo, T., Eikeseth, P. H., Tanum, L., Molden, E., & Refsum, H. (2006). The effect of variable cigarette consumption on the interaction with clozapine and olanzapine. European Journal of Clinical Pharmacology, 62, 1049–1053.CrossRefGoogle ScholarPubMed
Newman, W. J., & Newman, B. M. (2016). Rediscovering clozapine: Clinically relevant off-label uses. Current Psychiatry Reports, 15, 51–62.Google Scholar